Want to join the conversation?
$HBI said its gross and operating margins fell in 2Q16 due to about $12MM in costs associated with inventory-related actions. Interest and other expense, excluding one-time costs associated with refinancing actions, grew about $8MM due to increased debt balances, $6MM of which was due to company's decision to prefund its recent acquisitions.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.